Literature DB >> 1551742

Large differences in the biological half-life and volume of distribution of hydrochlorothiazide in normal subjects from eleven studies. Correlation with their last blood sampling times.

T M Chen1, W L Chiou.   

Abstract

In spite of more than three decades of wide use of hydrochlorothiazide as a diuretic, its mean biological half-life (t1/2) and apparent volume of distribution (Vdarea) in normal subjects were found to vary greatly among 11 studies reported between 1976 and 1986. For example, the mean t1/2 values ranged from 3.2 to 13.1 h and Vdarea values from 1.53 to 4.19 l/kg. Furthermore, a t1/2 of only 2.5 h and a Vdarea of only 0.83 l/kg were cited in a recent textbook. The present analyses show a positive correlation between the length of the last blood sampling time (tlast) employed and the t1/2 or Vdarea. The smaller t1/2 and Vdarea values reported were attributed to the insufficient length of time used in blood sampling for a drug exhibiting polyexponential disposition function. The kinetic and dynamic significance of the findings were briefly described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551742

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  7 in total

Review 1.  Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

Authors:  Sirirat Reungjui; Thongchai Pratipanawatr; Richard J Johnson; Takahiko Nakagawa
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

2.  Not just chlorthalidone: evidence-based, single tablet, diuretic alternatives to hydrochlorothiazide for hypertension.

Authors:  George C Roush; Michael E Ernst; John B Kostis; Ramandeep Kaur; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 3.  Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion; Iris Ambrosio-Perez
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 4.  Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.

Authors:  Caroline Fenton; Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.

Authors:  Domenic Sica; George L Bakris; William B White; Michael A Weber; William C Cushman; Patrick Huang; Andrew Roberts; Stuart Kupfer
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-06       Impact factor: 3.738

6.  Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression.

Authors:  Qiuhua Luo; Qianying Zhang; Puxiu Wang
Journal:  Pharmaceutics       Date:  2022-08-21       Impact factor: 6.525

7.  Pharmacokinetics of Hydrochlorothiazide in Children: A Potential Surrogate for Renal Secretion Maturation.

Authors:  Sarah Jane Commander; Huali Wu; Felix Boakye-Agyeman; Chiara Melloni; Chi Dang Hornik; Kanecia Zimmerman; Amira Al-Uzri; Susan R Mendley; Barrie Harper; Michael Cohen-Wolkowiez; Christoph P Hornik
Journal:  J Clin Pharmacol       Date:  2020-10-07       Impact factor: 2.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.